VeriMom¿Es palmitoyl tripeptide-1 seguro durante el embarazo?
No harmonised CLP classification or SCCS/CIR reproductive warnings identified for palmitoyl tripeptide‑1; peer‑reviewed reproductive toxicity data are not available. As a cosmetic signalling peptide with an N‑terminal palmitoyl to aid topical delivery, systemic reproductive hazard evidence is lacking (sources: ECHA Annex VI (no harmonised classification), PubChem, CosIng, PubMed literature absence). Exposure from topical cosmetic use is judged low but measurable due to palmitoylation enhancing skin delivery.
Pregnancy-safe products containing palmitoyl tripeptide-1
Related ingredients
Frequently asked questions
- ¿Es palmitoyl tripeptide-1 seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR reproductive warnings identified for palmitoyl tripeptide‑1; peer‑reviewed reproductive toxicity data are not available. As a cosmetic signalling peptide with an N‑terminal palmitoyl to aid topical delivery, systemic reproductive hazard evidence is lacking (sources: ECHA Annex VI (no harmonised classification), PubChem, CosIng, PubMed literature absence). Exposure from topical cosmetic use is judged low but measurable due to palmitoylation enhancing skin delivery.
- ¿Es palmitoyl tripeptide-1 seguro durante la lactancia?
- No data indicating reproductive or lactation-specific toxicity or transfer in milk. Mechanistic data for placental/milk transfer are absent; exposure from topical use is considered low but measurable in adults (sources: PubChem, CosIng, absence of SCCS/CIR warnings).
- ¿Es palmitoyl tripeptide-1 seguro para la piel del bebé?
- No infant‑specific toxicity data found. Given measurable (low) adult dermal availability and the immature barrier/higher surface‑area‑to‑weight in infants, exposure score is increased by +1 for 0–3 yr skin. No evidence of infant‑specific reproductive or mechanistic hazards (sources: CosIng, PubChem, EWG; no harmonised CLP flags).
- ¿Cómo puntúa VeriMom a palmitoyl tripeptide-1?
- VeriMom puntúa palmitoyl tripeptide-1 en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a palmitoyl tripeptide-1 en el embarazo?
- Consulta nuestra lista de alternativas seguras a palmitoyl tripeptide-1 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.